Trademark: C CADENT THERAPEUTICS 2093348
Word
C CADENT THERAPEUTICS
Device Descrption:
MOLECULAR-DIAGRAM FORMS LTR C
ID
2093348
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
26 February 2020
Registration Date
26 February 2020
Renewal Date
26 February 2030
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical preparations for the treatment of neurological conditions and psychiatric conditions; pharmaceutical preparations and substances for the treatment of movement and cognitive disorders; pharmaceutical preparations for the treatment of the central nervous system; pharmaceutical preparations for the treatment of essential tremor, spinocerebellar ataxia, depression, schizophrenia, and other diseases; pharmaceutical preparations for the treatment of neuropsychiatric conditions and neuro-developmental disorders.
Pharmaceutical preparations for the treatment of neurological conditions and psychiatric conditions; pharmaceutical preparations and substances for the treatment of movement and cognitive disorders; pharmaceutical preparations for the treatment of the central nervous system; pharmaceutical preparations for the treatment of essential tremor, spinocerebellar ataxia, depression, schizophrenia, and other diseases; pharmaceutical preparations for the treatment of neuropsychiatric conditions and neuro-developmental disorders.
Class 42:
Providing medical and scientific research in the fields of pharmaceuticals and clinical trials; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; research and development in the pharmaceutical, neurological, and neuropsychiatric fields; research and development of pharmaceutical preparations for movement and cognitive disorders.
Providing medical and scientific research in the fields of pharmaceuticals and clinical trials; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; research and development in the pharmaceutical, neurological, and neuropsychiatric fields; research and development of pharmaceutical preparations for movement and cognitive disorders.